仲村 秀太 (ナカムラ ヒデタ)

Nakamura Hideta

写真a

職名

助教

ホームページ

https://www.ryukyu-med1.com/

現在の所属組織 【 表示 / 非表示

  • 専任   琉球大学   医学研究科   助教  

出身大学 【 表示 / 非表示

  • 1997年04月
    -
    2003年03月

    琉球大学   医学部   医学科   卒業

留学歴 【 表示 / 非表示

  • 2016年04月
    -
    2018年03月

    Imperial College London  

取得学位 【 表示 / 非表示

  • 琉球大学 -  博士(医学)  ライフサイエンス / 感染症内科学

論文 【 表示 / 非表示

  • Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19

    Hideta Nakamura, Takeshi Kinjo, Wakako Arakaki, Kazuya Miyagi, Masao Tateyama, Jiro Fujita

    Critical Care ( Springer )  24 ( 1 ) 484 - 484   2020年08月 [ 査読有り ]

    掲載種別: 研究論文(学術雑誌)

  • Late diagnosis of HIV in 2022: Why so little change?

    Collins S, Namiba A, Sparrowhawk A, Strachan S, Thompson M, Nakamura H

    HIV medicine ( HIV Medicine )  23 ( 11 ) 1118 - 1126   2022年12月 [ 査読有り ]

    掲載種別: 研究論文(学術雑誌)

     概要を見る

    Background: The proportion of people who are diagnosed late is a key metric to measure the public health response to HIV. But this percentage remains stubbornly high in nearly every country. Delays in accessing antiretroviral therapy affects both (i) individual health, due to a higher risk of mortality, and (ii) population-based health, due to continued risk of transmission. Despite huge efforts to increase testing, late diagnosis continues to be an indication of a public health failure. Outline: This short review includes community perspectives on why late diagnosis continues and how it may be reduced. We discuss both structural barriers that prevent people from testing earlier and personal reasons why some people still refuse testing when offered. We note that late diagnosis is reported in all countries and in all demographic groups and that sex, gender, age, and sexuality all affect these rates. However, even in groups with high HIV awareness, such as in gay and bisexual men in the UK, more than one in three people with HIV continue to be diagnosed late. Fears and prejudice about HIV based on outdated information are still common among both health workers and people using health services. For example, testing is still not offered in primary or emergency care settings, and even free testing might not be accepted if someone fears the outcome might jeopardize their resident status, employment, relationship, or health. Summary: In addition to developing targeted projects to reach the highest-risk groups, a positive mainstream public campaign could make testing more acceptable at a broad population level across all demographics. This could challenge and repair the media campaigns from the 1980s that still contribute to the stigma that frightens people away from testing now. We hope that an effective approach in one country might also help others.

  • Subpleural Curvilinear Shadows Associated with COVID-19.

    Fujita J, Nakamura H, Miyagi K, Tateyama M

    Internal medicine (Tokyo, Japan) ( 一般社団法人 日本内科学会 )  60 ( 15 ) 2505 - 2506   2021年08月

    掲載種別: 研究論文(学術雑誌)

  • Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.

    Kinjo T, Hokama A, Nakamura H, Miyagi K, Higure Y, Otsuki M, Nishiyama N, Nakamatsu M, Kinjo T, Tateyama M, Fujita J

    The American journal of tropical medicine and hygiene ( American Journal of Tropical Medicine and Hygiene )  104 ( 5 ) 1655 - 1658   2021年03月 [ 査読有り ]

    掲載種別: 研究論文(学術雑誌)

  • Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients

    Hideta Nakamura, Gen Ouchi, Kazuya Miyagi, Yuuri Higure, Mariko Otsuki, Naoya Nishiyama, Takeshi Kinjo, Masashi Nakamatsu, Masao Tateyama, Ichiro Kukita, Jiro Fujita

    The American Journal of Tropical Medicine and Hygene   104 ( 3 ) 1018 - 1021   2021年01月 [ 査読有り ]

    掲載種別: 研究論文(学術雑誌)

全件表示 >>